TTrialPathMatch Me to Trials
← Back to trials
RecruitingMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Fatty Liver Disease, Nonalcoholic

Thermoacoustic Method for Estimating Liver Fat Fraction

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this study is to use our Thermoacoustic Enhanced Ultrasound device to measure the fat levels in your liver and compare it to the the gold standard MRI PDFF measurements. Participants will have a scan with our device, then they will go have an abdominal MRI completed. The goal is to create a more accessible device to measure liver fat as it is an indicator for overall health and metabolic diseases.

Sponsor: Endra Lifesciences

You may qualify if…

  • Study participants are 18 or older.
  • Able to understand, read, and provide written informed consent in English.
  • Able to tolerate both ultrasound and MRI examinations.
  • Able to lie flat, or on their side, for 20 minutes and pause breathing for up to 10 seconds.

You may not qualify if…

  • Metal or electronic implants, including, but not limited to: pacemakers, metal clips, drug delivery pumps, hip implants, and neural stimulation devices, contraindicates for MRI.
  • Known pregnancy the day of consent or becoming pregnant during study participation based on start date of last menstrual period).
  • Liver diseases other than MASLD/MASH/fibrosis including, but not limited to:
  • Cirrhosis
  • Hepatocellular carcinoma
  • Ascites
  • Patients with broken, or injured skin, in the right upper abdominal quadrant.
  • Body habitus, or anatomical variation, where the liver capsule is not accessible with ultrasound through the patient's right intercostal imaging window used in conventional ultrasound liver imaging.

Where it's recruiting

Michigan

Ann Arbor

Source: ClinicalTrials.gov · NCT07321925 · last updated 2026-01-07